Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Infection (Healthy Volunteers)”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04450498
What this trial is testing

Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years

Who this might be right for
Neisseria Meningitides Meningitis
Walvax Biotechnology Co., Ltd. 260
Large-scale testing (Phase 3)Study completedNCT01641042
What this trial is testing

Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 86
Large-scale testing (Phase 3)Study completedNCT06228586
What this trial is testing

Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam

Who this might be right for
Meningococcal InfectionHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 447
Early research (Phase 1)Ended earlyNCT01164514
What this trial is testing

Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant

Who this might be right for
Bacterial Sepsis
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT00329901
What this trial is testing

Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,072
Testing effectiveness (Phase 2)Study completedNCT02531698
What this trial is testing

Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years

Who this might be right for
MENINGOCOCCAL INFECTION
Pfizer 400
Not applicableEnded earlyNCT03549325
What this trial is testing

A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14

Who this might be right for
Meningitis, Meningococcal
University Hospital Southampton NHS Foundation Trust 21
Large-scale testing (Phase 3)Study completedNCT03632720
What this trial is testing

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 788
Testing effectiveness (Phase 2)Study completedNCT00356369
What this trial is testing

Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Large-scale testing (Phase 3)Study completedNCT02141516
What this trial is testing

Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.

Who this might be right for
Meningococcal Disease
Novartis 239
Testing effectiveness (Phase 2)Study completedNCT01165242
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,013
Large-scale testing (Phase 3)Study completedNCT01973218
What this trial is testing

Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years.

Who this might be right for
Meningococcal Disease
Novartis Vaccines 264
Large-scale testing (Phase 3)UnknownNCT05252715
What this trial is testing

Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months

Who this might be right for
Meningitis, Meningococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,200
Large-scale testing (Phase 3)Study completedNCT03869866
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 290
Large-scale testing (Phase 3)Study completedNCT04318548
What this trial is testing

Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 945
Large-scale testing (Phase 3)Study completedNCT03691610
What this trial is testing

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 950
Testing effectiveness (Phase 2)Study completedNCT00196963
What this trial is testing

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 125
Testing effectiveness (Phase 2)Study completedNCT03587207
What this trial is testing

Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 520
Large-scale testing (Phase 3)Study completedNCT00453986
What this trial is testing

Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,352
Large-scale testing (Phase 3)Study completedNCT00514904
What this trial is testing

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects

Who this might be right for
Infections, MeningococcalMeningococcal Vaccines
GlaxoSmithKline 1,504
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation